News and Press Releases

Biogen Receives European Commission Approval for QALSODY (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS

SOD1-ALS is a devastating, uniformly fatal and ultra-rare genetic form of ALS estimated to affect less than 1,000 people in Europe QALSODY is Biogen’s third rare disease therapy to be...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: May 30, 2024

Biogen International GmbH Neuhofstrasse 30 6340 Baar Switzerland

Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024

23 May 2024 -- Tokyo, Japan -- Eisai Co announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American...

Category: Clinical Trials, Drug Discovery
Posted: May 23, 2024

4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan

Global oncology trial investigator sites increase by half in five years, finds new Phesi analysis

China flagged as significant contributor to growth, but poor investigator selection is causing trial failures 23 May 2024 -- Massachusetts, US -- Phesi, a leading clinical development analytics company, has...

Category: Biotechnology, Clinical Trials
Posted: May 22, 2024

East Lyme, Connecticut, US

During BIO Show, PCI Pharma Services to Highlight Sterile Fill-Finish Robotics Technologies at Nearby San Diego Manufacturing Plant

Robotics-assisted systems support sterile filling of vials, prefilled syringes and cartridges during clinical trials, substantially limiting drug product loss while reducing timeline 20 May 2024 -- Pennsylvania, US -- PCI...

Category: Biotechnology, Manufacturing and Packing, Other
Posted: May 20, 2024

3001 Red Lion Road, Philadelphia, PA 19114, USA

Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024

Non-Small Cell Lung Cancer (NSCLC) Development Program Data to be Presented, Including the phase 3 EVOKE-01 Study Updated Results from phase 2 EDGE-Gastric Study of Fc-Silent Anti-TIGIT Domvanalimab Plus Anti-PD-1...

Category: Clinical Trials, Drug Discovery
Posted: May 7, 2024

2400 Broadway Santa Monica, CA 90404

Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site

6 May 2024 -- Minnesota, US, and Missouri, US -- Kindeva Drug Delivery, a global leader in drug-device combination products, today announced its investment in a second manufacturing line for...

Category: Drug Delivery, Manufacturing and Packing
Posted: May 6, 2024

Revolutionising Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable 2 May 2024 -- Raleigh, North Carolina -- ProPharma, the leading global provider of regulatory, clinical and compliance services...

Category: BioManufacturing, Clinical Trials, Drug Discovery
Posted: May 2, 2024

107 West Hargett St. Raleigh, NC 27601

Asahi Kasei Bioprocess to Unveil THESYS ACS ERGO Synthesis Column at TIDES USA – offering reduced changeover time while maintaining safety and product quality

30 April 2024 -- Düsseldorf, Germany; Tokyo, Japan; and New York, US -- Generating cutting-edge therapeutics requires precision, safety and efficiency from manufacturing equipment. The next generation of oligo manufacturing,...

Category: BioManufacturing, Manufacturing and Packing
Posted: April 30, 2024

1-1-2 Yurakucho, Chiyoda-ku, Tokyo 100-0006 Japan

Kite to Present Comparison of Outcomes of Tecartus (brexucabtagene autoleucel) from the Pivotal ZUMA-2 Trial Versus the EBMT Registry of alloSCT Patients in Mantle Cell Lymphoma (MCL) at 50th EBMT 2024

Additional analysis demonstrates cost-effectiveness of axicabtagene ciloleucel versus standard of care as second-line therapy In patients With large B-cell lymphoma In Italy 9 April 2024 -- Stockley Park, UK --...

Category: Biotechnology, Clinical Trials
Posted: April 12, 2024

2400 Broadway Santa Monica, CA 90404

NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumour Biology in a Paired Biopsy Clinical Study

NUC-7738 reprogrammes cancer cell lipid metabolism to make tumours less aggressive and promote cancer cell death NUC-7738 alters ribosome biogenesis and the regulation of genes critical for cancer growth and...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: April 10, 2024

https://www.nucana.com/

Nonacus launches test for comprehensive genomic profiling, integrated with bioinformatics and analysis software

2 April 2024 -- Birmingham, UK -- Genetic testing company, Nonacus, has launched GALEAS Tumor, a next generation sequencing (NGS) test that provides comprehensive genomic profiling of tumours, allowing clinicians...

Category: Biotechnology
Posted: April 2, 2024

Unit 5, Quinton Business Park, 11 Ridgeway, Quinton, Birmingham B32 1AF, United Kingdom

SMC Ltd Announces Expansion of Sterile Fill Finish Capabilities, Unveiling State-of-the-Art Facility in North Carolina, US

26 March 2024 -- Wisconsin, US -- SMC Ltd, the worldwide contract manufacturer of single use and disposable medical devices, has today announced the acquisition of an end-to-end fill/finish facility...

Category: Manufacturing and Packing
Posted: March 26, 2024

330 SMC Drive Somerset WI 54025 U.S.A

Gilbert To Officially Open New Development and GMP Manufacturing Facility

22 March 2024 -- Nottingham, UK -- UK-based contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions was joined by Oxford/AstraZeneca COVID-19 vaccine co-inventor Professor Dame Sarah Gilbert, biotech industry representatives and...

Category: BioManufacturing, Clinical Trials, Manufacturing and Packing
Posted: March 22, 2024

Albert Einstein Centre, Nottingham Science Park, Nottingham, UK, NG7 2TN

Eisbach and Cancer Focus Fund Announce $4.5m Investment to Support First-in-Human Phase 1/2 Trial of EIS-12656 for Refractory Advanced Solid Tumours

Eisbach is enabling the potential of synthetic lethality by developing novel compounds to exploit molecular vulnerabilities uniquely present in many hard-to-treat cancers 21 March 2024 -- Martinsried, Germany and Texas, US...

Category: Biotechnology, Pharmaceutical
Posted: March 21, 2024

Am Klopferspitz 19, 82152 Planegg, Germany

TMC Pharma champions holistic approach to medical services in rare disease drug development

13 March 2024 – In a recent webinar, rare disease specialist and global clinical research organisation (CRO) TMC Pharma gathered esteemed speakers to share insights into the scope of medical...

Category: Drug Discovery, Pharmaceutical
Posted: March 13, 2024

Lodge Farm Barn Elvetham Park Estate, Fleet Road, Hartley Wintney, Hampshire RG27 8AS, UK